N

Minerva Neurosciences

D
NERV
USD
0.01
(0.4237%)
Market Closed
100.000
Volume
-2.26
EPS
-
Div Yield
-0.538636
P/E
16,574,372.22
Market Cap
Today
0.4237%
1 Week
-1.250%
1 Month
-12.222%
6 Months
-8.494%
12 Months
-55.028%
Year To Date
-60.826%
All Time
0%

Title:
Minerva Neurosciences

Sector:
Healthcare
Industry:
Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
Do you need help or have a question?